Valuation: AstraZeneca PLC

Capitalization 311B 263B 243B 229B 427B 28,983B 434B 2,848B 1,115B 13,915B 1,167B 1,142B 49,406B P/E ratio 2026 *
25.3x
P/E ratio 2027 * 22.3x
Enterprise value 330B 279B 258B 243B 453B 30,750B 460B 3,022B 1,183B 14,763B 1,238B 1,212B 52,417B EV / Sales 2026 *
5.22x
EV / Sales 2027 * 4.8x
Free-Float
96.62%
Yield 2026 *
1.66%
Yield 2027 * 1.76%
1 day-1.02%
1 week-2.96%
Current month+0.52%
1 month+2.68%
3 months+5.28%
6 months+16.78%
Current year+7.08%
1 week 14,765.11
Extreme 14765.114
15,450
1 month 13,478
Extreme 13478
15,450
Current year 13,268
Extreme 13268
15,732
1 year 9,651
Extreme 9651
15,732
3 years 9,461
Extreme 9461
15,732
5 years 7,301
Extreme 7301
15,732
10 years 3,680
Extreme 3680
15,732
Manager TitleAgeSince
Chief Executive Officer 65 2012-09-30
Director of Finance/CFO 52 2021-07-31
Chief Tech/Sci/R&D Officer - 2023-07-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 65 2012-09-30
Director/Board Member 65 2017-04-26
Change 5d. change 1-year change 3-years change Capi.($)
-1.02%-2.96%+43.64%+24.17% 311B
-1.89%-5.06%+19.53%+141.52% 810B
-0.60%-1.09%+55.36%+43.92% 575B
-0.05%-1.50%+17.88%+28.98% 369B
-0.35%+0.48%+23.57%+13.94% 324B
-1.72%-4.29%+50.40%+2.25% 291B
-1.61%-2.34%+31.20%+35.32% 289B
-0.78%-0.45%+17.92%+39.29% 188B
-0.48%-1.25%+32.26%+68.40% 173B
+2.32%+4.89%-40.83%-55.99% 176B
Average -0.45%-1.06%+25.09%+34.18% 350.69B
Weighted average by Cap. -0.36%-1.28%+28.77%+52.13%

Financials

2026 *2027 *
Net sales 63.18B 53.52B 49.35B 46.54B 86.8B 5,890B 88.2B 579B 227B 2,828B 237B 232B 10,040B 67.07B 56.82B 52.39B 49.4B 92.14B 6,252B 93.63B 614B 241B 3,002B 252B 246B 10,658B
Net income 12.5B 10.59B 9.76B 9.21B 17.17B 1,165B 17.45B 115B 44.82B 559B 46.9B 45.91B 1,986B 14.11B 11.95B 11.02B 10.39B 19.39B 1,315B 19.7B 129B 50.6B 632B 52.95B 51.84B 2,242B
Net Debt 18.95B 16.05B 14.8B 13.96B 26.03B 1,766B 26.45B 174B 67.95B 848B 71.1B 69.61B 3,011B 11.01B 9.33B 8.6B 8.11B 15.13B 1,026B 15.37B 101B 39.48B 493B 41.31B 40.44B 1,749B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-04-15 14,766.00 p -1.02% 2,164,921
26-04-14 14,918.00 p -0.47% 1,318,293
26-04-13 14,988.00 p -1.59% 1,951,201
26-04-10 15,230.00 p -0.30% 2,342,633
26-04-09 15,276.00 p +0.39% 2,694,111
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
200.47USD
Average target price
220.22USD
Spread / Average Target
+9.85%

Quarterly revenue - Rate of surprise